These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 3072539)

  • 21. Guanfacine: a new centrally-acting antihypertensive agent.
    Beevers DG; Bloxham CA; Walker JM
    Pharmatherapeutica; 1981; 2(8):513-6. PubMed ID: 7019931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Use of the hypotensive drug guanfacine in the treatment of patients with hypertension].
    Kravchenko IG; Liashenko MM; Tarnakin AG; Chirkov SN
    Kardiologiia; 1986 Mar; 26(3):41-5. PubMed ID: 3520085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term antihypertensive therapy with guanfacine.
    Szám I; Holló J
    Int J Clin Pharmacol Ther Toxicol; 1982 Aug; 20(8):388-92. PubMed ID: 6749702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Guanfacine in the treatment of arterial hypertension. Apropos of 471 cases in a hospital milieu].
    Carette B
    Ann Cardiol Angeiol (Paris); 1984; 33(2):123-6. PubMed ID: 6143529
    [No Abstract]   [Full Text] [Related]  

  • 25. Prolactin, renin, growth hormone, lipoproteins and glucose under guanfacine treatment.
    Hauger-Klevene JH; Balossi EC; Scornavacchi JC
    Cor Vasa; 1987; 29(4 Suppl 1):17-22. PubMed ID: 3119290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of long-term treatment with guanfacine on selected humoral metabolic indices in patients with primary hypertension].
    Knypl K; Wocial B; Chodakowska J; Brym E; Czerniewska E; Wacławek-Maczkowska J; Kuczyńska K; Berent H; Januszewicz W
    Pol Tyg Lek; 1989 Mar 20-27; 44(12-13):293-6. PubMed ID: 2530502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Guanfacine in the treatment of hypertensives with a pronounced response to exercise and diabetes mellitus.
    Dvorák I; Podrouzková B; Kocourková J; Kubesová H; Spác J; Nĕmcová H; Blaha M
    Cor Vasa; 1987; 29(4 Suppl 1):30-6. PubMed ID: 3315448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemodynamic effects of guanfacine in essential hypertension.
    Feldstein CA; Cohen AA; Sabaris RP; Burucúa JE
    Clin Ther; 1984; 6(3):325-34. PubMed ID: 6373009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of long-term treatment of essential hypertension with guanfacine.
    Higuchi M; Overlack A; Stumpe KO
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):61S-64S. PubMed ID: 6994780
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Guanfacinum (BS 100-14) in long-term therapy of severe hypertension].
    Röckel A; Sabel B; Heidland A
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():314-8. PubMed ID: 347805
    [No Abstract]   [Full Text] [Related]  

  • 31. [Cross-over double-blind study of the antihypertensive action of N-amidino-2-(2,6-dichlorophenyl)acetamide-hydrochloride and clonidine].
    Kirch W; Distler A
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():318-21. PubMed ID: 347806
    [No Abstract]   [Full Text] [Related]  

  • 32. [Antihypertensive therapy with guanfacine. A multicenter trial with Estulic Wander 1 mg].
    Schäfer N; Knaup G
    MMW Munch Med Wochenschr; 1982 Mar; 124(10):249-52. PubMed ID: 6806612
    [No Abstract]   [Full Text] [Related]  

  • 33. A comparative study of a new alpha-adrenoceptor agonist, guanfacine and alpha-methyldopa in the treatment of hypertension.
    Joshi RC; De A; Cameron EG
    Br J Clin Pract; 1984 Feb; 38(2):66-7, 71. PubMed ID: 6142723
    [No Abstract]   [Full Text] [Related]  

  • 34. [Controlled doubleblind study on dose-effect relationship of guanfacine a long-acting hypotensive guanidine derivative (author's transl)].
    Magometschnigg D; Bonelli J; Hitzenberger G; Kaik G
    Arzneimittelforschung; 1980; 30(6):1005-7. PubMed ID: 6998487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A clinical study of guanfacine in the treatment of arterial hypertension].
    Kheder A; Souilem J; Hassine L; Ben Maiz H; Ben Moussa F; Ben Ayed H
    Tunis Med; 1987 Nov; 65(11):709-12. PubMed ID: 3332951
    [No Abstract]   [Full Text] [Related]  

  • 36. [Guanfacine (Estulic) in the monotherapy of essential hypertension, grades I and II, according to WHO].
    Mayer K; Lupínek Z; Janousek S; Podrouzková B
    Cas Lek Cesk; 1984 Oct; 123(43):1306-11. PubMed ID: 6391673
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparison of antihypertensive activity and tolerability of guanfacine and methyldopa.
    Malini PL; Strocchi E; Ambrosioni E; Magnani B
    Int J Clin Pharmacol Res; 1983; 3(1):35-9. PubMed ID: 6384071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical experience with guanfacine in long-term treatment of hypertension. Part II: adverse reactions to guanfacine.
    Jerie P
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):157S-164S. PubMed ID: 6994770
    [No Abstract]   [Full Text] [Related]  

  • 39. [Improvement of the functional capacity of hypertensive patients treated with guanfacine].
    Bazika V; Neuzil P; Tiserová J; Hrabovský F
    Cas Lek Cesk; 1986 May; 125(21):637-40. PubMed ID: 3518943
    [No Abstract]   [Full Text] [Related]  

  • 40. [Extracardiac systemic pharmacodynamic effects of estulic (guanfacine)].
    Kukes VG; Spasskiĭ AV; Tsoĭ AN; Blinkov IL; Karpenko EV
    Klin Med (Mosk); 1987 Jan; 65(1):46-9. PubMed ID: 3550283
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.